NKILA and laryngeal carcinoma: Through combining with NF‐κB: IκB complex, NKILA reduced IκB phosphorylation and NF‐κB activation, inhibited p65 nuclear translocation, thereby sensitizing laryngeal cancer to radiotherapy.